Cost-Effectiveness Analysis of a Randomized Trial Comparing Care Models for Chronic Kidney Disease | Zendy

Robert Hopkins | Zendy; Amit X. Garg | Zendy; Adeera Levin | Zendy; Anita Molzahn | Zendy; Claudio Rigatto | Zendy; Joel Singer | Zendy; George Soltys | Zendy; Steven D. Soroka | Zendy; Patrick S. Parfrey | Zendy; Brendan J. Barrett | Zendy; Ron Goeree | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Cost-Effectiveness Analysis of a Randomized Trial Comparing Care Models for Chronic Kidney Disease

Author(s) -

Robert Hopkins,

Amit X. Garg,

Adeera Levin,

Anita Molzahn,

Claudio Rigatto,

Joel Singer,

George Soltys,

Steven D. Soroka,

Patrick S. Parfrey,

Brendan J. Barrett,

Ron Goeree

Publication year - 2011

Publication title -

clinical journal of the american society of nephrology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.755

H-Index - 151

eISSN - 1555-905X

pISSN - 1555-9041

DOI - 10.2215/cjn.07180810

Subject(s) - medicine , nephrology , kidney disease , randomized controlled trial , cost effectiveness , intensive care medicine , quality of life (healthcare) , intervention (counseling) , cost effectiveness analysis , disease , emergency medicine , physical therapy , nursing , risk analysis (engineering)

Potential cost and effectiveness of a nephrologist/nurse-based multifaceted intervention for stage 3 to 4 chronic kidney disease are not known. This study examines the cost-effectiveness of a chronic disease management model for chronic kidney disease.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research